Veerhealth Care is currently trading at Rs. 22.98, up by 0.17 points or 0.75% from its previous closing of Rs. 22.81 on the BSE.
The scrip opened at Rs. 23.20 and has touched a high and low of Rs. 23.48 and Rs. 22.75 respectively. So far 220479 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 27.00 on 26-Jul-2024 and a 52 week low of Rs. 9.29 on 04-Mar-2025.
Last one week high and low of the scrip stood at Rs. 23.48 and Rs. 19.92 respectively. The current market cap of the company is Rs. 45.72 crore.
The promoters holding in the company stood at 31.50%, while Non-Institutions held 68.50% respectively.
Veerhealth Care has received mandatory regulatory approval from the Food and Drug Authority, Gujarat for manufacturing and supply of personal care products for one of the India's leading marketplace company.
In addition to the regulatory approval, the company has also received its first commercial order for manufacture and supply of products in personal care category. This order is for products in skin care and face care segment and going forward more products would be added to the contract manufacturing portfolio. This development is expected to contribute positively to the Company's revenues. The size of order is Rs 0.48 crore. The said order is to be executed in 30 days.
Veerhealth Care is engaged mainly in business of trading and manufacturing and marketing research based ayurvedic medicines.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: